IS4923A - Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara - Google Patents

Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara

Info

Publication number
IS4923A
IS4923A IS4923A IS4923A IS4923A IS 4923 A IS4923 A IS 4923A IS 4923 A IS4923 A IS 4923A IS 4923 A IS4923 A IS 4923A IS 4923 A IS4923 A IS 4923A
Authority
IS
Iceland
Prior art keywords
atpase
blockers
administration
treatment plans
extended
Prior art date
Application number
IS4923A
Other languages
English (en)
Other versions
IS2216B (is
Inventor
Cederberg Christer
Sachs George
Original Assignee
Astra Aktiebolag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag
Publication of IS4923A publication Critical patent/IS4923A/is
Publication of IS2216B publication Critical patent/IS2216B/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
IS4923A 1996-06-20 1998-12-15 Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla IS2216B (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9602442A SE9602442D0 (sv) 1996-06-20 1996-06-20 Administration of pharmaceuticals
PCT/SE1997/001098 WO1997048380A1 (en) 1996-06-20 1997-06-18 ADMINISTRATION REGIMEN OF H+, K+-ATPase INHIBITORS

Publications (2)

Publication Number Publication Date
IS4923A true IS4923A (is) 1998-12-15
IS2216B IS2216B (is) 2007-03-15

Family

ID=20403092

Family Applications (1)

Application Number Title Priority Date Filing Date
IS4923A IS2216B (is) 1996-06-20 1998-12-15 Meðferðaráform við inngjöf á H+,K+ -ATPasa-hemla

Country Status (28)

Country Link
US (4) US20010008900A1 (is)
EP (1) EP0921787B1 (is)
JP (1) JP2000512993A (is)
CN (1) CN1178648C (is)
AT (1) ATE252885T1 (is)
AU (1) AU726859B2 (is)
BR (1) BR9709838A (is)
CA (1) CA2257405A1 (is)
CZ (1) CZ298213B6 (is)
DE (1) DE69725860T2 (is)
DK (1) DK0921787T3 (is)
EE (1) EE04606B1 (is)
ES (1) ES2208921T3 (is)
HK (1) HK1018590A1 (is)
HU (1) HUP9901794A3 (is)
IL (2) IL127542A0 (is)
IS (1) IS2216B (is)
NO (1) NO323295B1 (is)
NZ (1) NZ332990A (is)
PL (1) PL189716B1 (is)
PT (1) PT921787E (is)
RS (1) RS49590B (is)
RU (1) RU2203662C2 (is)
SE (1) SE9602442D0 (is)
SK (1) SK284204B6 (is)
TR (1) TR199802647T2 (is)
UA (1) UA64715C2 (is)
WO (1) WO1997048380A1 (is)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US5968547A (en) 1997-02-24 1999-10-19 Euro-Celtique, S.A. Method of providing sustained analgesia with buprenorphine
GB9720061D0 (en) 1997-09-19 1997-11-19 Crosfield Joseph & Sons Metal compounds as phosphate binders
SE9704870D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulation I
SE9704869D0 (sv) * 1997-12-22 1997-12-22 Astra Ab New pharmaceutical formulaton II
CA2330139A1 (en) * 1998-04-30 1999-11-04 Sepracor Inc. R-rabeprazole compositions and methods
JP2002512263A (ja) * 1998-04-30 2002-04-23 セプラコール， インク． Ｓ−レイブプラゾール組成物及び方法
CN100396675C (zh) 1998-08-10 2008-06-25 加利福尼亚州大学董事会 质子泵抑制剂的前药
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
SI1105105T1 (sl) 1998-08-12 2006-08-31 Altana Pharma Ag Oralna dajalna oblika za piridin-2-ilmetilsulfinil-1J-benzimidazole
US20050048077A1 (en) * 2002-02-21 2005-03-03 George Sachs Compositions, test kits and methods for detecting helicobacter pylori
MY148805A (en) * 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
TWI372066B (en) 2003-10-01 2012-09-11 Wyeth Corp Pantoprazole multiparticulate formulations
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
CA2570916C (en) 2004-06-16 2013-06-11 Tap Pharmaceutical Products, Inc. Pulsed release dosage form of a ppi
MY157620A (en) 2006-01-31 2016-06-30 Cytochroma Dev Inc A granular material of a solid water-soluble mixed metal compound capable of binding phosphate
GB0714670D0 (en) 2007-07-27 2007-09-05 Ineos Healthcare Ltd Use
GB0720220D0 (en) 2007-10-16 2007-11-28 Ineos Healthcare Ltd Compound
GB0913525D0 (en) 2009-08-03 2009-09-16 Ineos Healthcare Ltd Method
GB201001779D0 (en) 2010-02-04 2010-03-24 Ineos Healthcare Ltd Composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
CA2161256C (en) * 1993-04-27 2004-06-29 Nancy M. Gray Methods and compositions for treating gastric disorders using optically pure (-) pantoprazole
SE9402431D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New tablet formulation
EP0723436B1 (en) * 1994-07-08 2001-09-26 AstraZeneca AB Multiple unit tableted dosage form i
US6132768A (en) * 1995-07-05 2000-10-17 Byk Gulden Lomberg Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for reversible proton pump inhibitors
US5945124A (en) * 1995-07-05 1999-08-31 Byk Gulden Chemische Fabrik Gmbh Oral pharmaceutical composition with delayed release of active ingredient for pantoprazole

Also Published As

Publication number Publication date
CN1222074A (zh) 1999-07-07
NZ332990A (en) 2000-07-28
EE04606B1 (et) 2006-04-17
NO323295B1 (no) 2007-03-05
NO985964L (no) 1999-02-22
PL189716B1 (pl) 2005-09-30
YU56698A (sh) 2004-12-31
NO985964D0 (no) 1998-12-18
DK0921787T3 (da) 2004-02-23
ES2208921T3 (es) 2004-06-16
CA2257405A1 (en) 1997-12-24
UA64715C2 (en) 2004-03-15
RU2203662C2 (ru) 2003-05-10
SK284204B6 (sk) 2004-10-05
SE9602442D0 (sv) 1996-06-20
PL330910A1 (en) 1999-06-07
AU726859B2 (en) 2000-11-23
HUP9901794A2 (hu) 2000-04-28
BR9709838A (pt) 1999-08-10
ATE252885T1 (de) 2003-11-15
SK165598A3 (en) 1999-08-06
CZ420398A3 (cs) 2000-02-16
TR199802647T2 (xx) 1999-03-22
US20010008900A1 (en) 2001-07-19
US20090036494A1 (en) 2009-02-05
WO1997048380A1 (en) 1997-12-24
HK1018590A1 (en) 1999-12-30
US20070276007A1 (en) 2007-11-29
CZ298213B6 (cs) 2007-07-25
DE69725860D1 (de) 2003-12-04
IL127542A0 (en) 1999-10-28
PT921787E (pt) 2004-03-31
DE69725860T2 (de) 2004-09-09
EE9800435A (et) 1999-06-15
EP0921787A1 (en) 1999-06-16
IL127542A (en) 2006-08-01
JP2000512993A (ja) 2000-10-03
IS2216B (is) 2007-03-15
RS49590B (sr) 2007-06-04
EP0921787B1 (en) 2003-10-29
HUP9901794A3 (en) 2002-11-28
CN1178648C (zh) 2004-12-08
AU3469097A (en) 1998-01-07
US20050113418A1 (en) 2005-05-26

Similar Documents

Publication Publication Date Title
IS4923A (is) Meðferðaráform við inngjöf á H+,K+-ATPasa-blokkara
DE60030741D1 (de) Chinazoline verbindungen als heilmittel
CO5011096A1 (es) Medicamentos que contienen antagonistas del receptor 5-ht3 para el tratamiento de la ibs
SE9504661D0 (sv) New compounds
DK0869808T3 (da) Anvendelse af Glu-Trp-dipeptider til fremstilling af et lægemiddel til behandling af forskellige tilstande, der involverer neovaskularisation
MX9700885A (es) Nuevas heteroariloxazolidinonas.
AP9701041A0 (en) Pyridylpyrrole compounds.
AU3475097A (en) Substituted cyclopentane compounds useful as neuraminidase inhibitors
IT1285770B1 (it) Composti corticoidei
DK0998287T3 (da) Anvendelse af levobupivacain
DK0688215T3 (da) 3,4-diarylchromaner til behandling af dermatitis
ES2193233T3 (es) Uso de amiodipina, una sal de la misma o felodipina en combinacion con un inhibidor ace en la fabricacion de un medicamento para el tratamiento de insuficiencia cardiaca conjuntiva no isquemica.
DK0736029T3 (da) Antikonvulsive pseudofructopyranosesulfamater
DK1150704T3 (da) Melagatran til behandling af betændelse
IT1318667B1 (it) Medicamento antinfiammatorio.
DK0479093T3 (da) Oligosaccharidderivater og deres anvendelse som lægemidler
DK0825865T3 (da) Transdermalt, terapeutisk system for administrering af testosteron eller testosteronderivat
EE05241B1 (et) Distamtsiini a-halogenoakrlolderivaadi kasutamine
SE9504662D0 (sv) New compounds
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
MD1744F2 (ro) Săruri ale acidului clavulanic şi procedeu de obţinere a lor
ES2175153T3 (es) Uso de inhibidores de colinesterasa para la fabricacion de un medicamento para el tratamiento de la xerostomia.
NO984651L (no) Anvendelse av benzonaftalenderivater for fremstilling av medikamenter for behandling av sykdommer i sentralnervesystemet
DE69412612D1 (de) Desoxyazaphospholipid-derivate mit inhibierender aktivität auf phospholipase
NO952234L (no) Transdermalt administreringsystem inneholdende acetylsalisylsyre for antitromboseterapi og forebygging av kreft